Lung Function Responder Rates in the Voyage Study in Children with Moderate-to-severe Type 2 Asthma Receiving Dupilumab

被引：0
|
作者：
Guilbert, T. W. [1 ,2 ]
Fiocchi, A. G. [3 ]
Murphy, K. R. [4 ]
Hamelmann, E. [5 ]
Ross, K. [6 ]
Gupta, A. [7 ]
Xia, C. [8 ]
Gall, R. [8 ]
Ledanois, O. [9 ]
Radwan, A. [8 ]
Jacob-Nara, J. A. [10 ]
Rowe, P. J. [10 ]
Deniz, Y. [8 ]
机构：
[1] Cincinnati Childrens Hosp, Cincinnati, OH USA
[2] Univ Cincinnati, Cincinnati, OH USA
[3] Bambino Gesu Childrens Hosp IRCCS, Rome, Italy
[4] Boys Town Natl Res Hosp, Boys Town, NE USA
[5] Univ Bielefeld, Bielefeld, Germany
[6] Case Western Reserve Univ, Cleveland, OH USA
[7] Kings Coll Hosp London, London, England
[8] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[9] Sanofi, Paris, France
[10] Sanofi, Bridgewater, France
来源：
PEDIATRIC PULMONOLOGY | 2023年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
A 10
引用
收藏
页码：S93 / S93
页数：1
相关论文
共 50 条
  • [1] Dupilumab improves lung function responder rates in children with type 2 asthma in the VOYAGE study
    Guilbert, Theresa
    Fiocchi, Alessandro G.
    Murphy, Kevin R.
    Hamelmann, Eckard
    Ross, Kristie
    Gupta, Atul
    Xia, Changming
    Gall, Rebecca
    Ledanois, Olivier
    Radwan, Amr
    Jacob-Nara, Juby A.
    Rowe, Paul J.
    Deniz, Yamo
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [2] Dupilumab Improves Lung Function in Children With Uncontrolled, Moderate-to-Severe Asthma: LIBERTY ASTHMA VOYAGE
    Bacharier, B. L.
    Guilbert, W. T.
    Katelaris, H. C.
    Deschildre, A.
    Liu, D.
    Mannent, P. L.
    Amin, N.
    Laws, E.
    Ruddy, M.
    Ortiz, B.
    Jacob-Nara, A. J.
    Deniz, Y.
    Rowe, J. P.
    Atenhan, A.
    Thakur, M.
    Lederer, J. D.
    Hardin, M.
    PNEUMOLOGIE, 2022, 76 : S40 - S40
  • [3] Dupilumab Improves Lung Function in Children with Uncontrolled, Moderate-to-Severe Asthma: LIBERTY ASTHMA VOYAGE
    Bacharier, L. B.
    Guilbert, T. W.
    Katelaris, C. G.
    Deschildre, A.
    Liu, D.
    Mannent, L. P.
    Laws, E.
    Ruddy, M.
    Jacob-Nara, J. A.
    Deniz, Y.
    Rowe, P. J.
    Lederer, D. J.
    Hardin, M.
    PEDIATRIC PULMONOLOGY, 2022, 57 : S97 - S98
  • [4] DUPILUMAB IMPROVES LUNG FUNCTION IN CHILDREN WITH UNCONTROLLED, MODERATE-TO-SEVERE ASTHMA: LIBERTY ASTHMA VOYAGE
    Bacharier, Leonard
    Guilbert, Theresa
    Katelaris, Constance
    Deschildre, Antoine
    Liu, Dongfang
    Mannent, Leda
    Amin, Nikhil
    Laws, Elizabeth
    Ruddy, Marcella
    Ortiz, Benjamin
    Jacob-Nara, Juby
    Deniz, Yamo
    Rowe, Paul
    Lederer, David
    Hardin, Megan
    CHEST, 2021, 160 (04) : 1885A - 1887A
  • [5] Dupilumab Improves Lung Function in Children With Moderate-to-Severe Type 2 Asthma at Week 12
    Guilbert, T. W.
    Deschildre, A.
    Murphy, K. R.
    Hamelmann, E.
    Ross, K. R.
    Gupta, A.
    Xia, C.
    Gall, R.
    Ledanois, O.
    Radwan, A.
    Jacob-Nara, J. A.
    Rowe, P. J.
    Deniz, Y.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [6] Improved Lung Function Is Associated With Better Asthma Control in Children With Moderate-to-Severe Type 2 Asthma: Voyage Study
    Bacharier, L. B.
    Dell, S.
    De Mir-Messa, I.
    Piacentini, G.
    Hamelmann, E.
    Msihid, J.
    Gall, R.
    Ledanois, O.
    Wang, Z.
    Cheng, W.
    Sacks, H.
    Jacob-Nara, J. A.
    Rowe, P. J.
    Deniz, Y.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [7] Dupilumab Efficacy in Children with Uncontrolled, Moderate-to-severe Type 2 Asthma, with and Without Evidence of Allergic Asthma in the VOYAGE Phase 3 Study
    Papadopoulos, Nikolaos G.
    Szefler, Stanley J.
    Bacharier, Leonard B.
    Maspero, Jorge F.
    Domingo, Christian
    Daizadeh, Nadia
    Lederer, David J.
    Hardin, Megan
    Jacob-Nara, Juby A.
    Deniz, Yamo
    Gall, Rebecca
    Ortiz, Benjamin
    Djandji, Michel
    Rowe, Paul J.
    PEDIATRICS, 2022, 149 (01)
  • [8] Dupilumab reduced impact of severe exacerbations on lung function in patients with moderate-to-severe type 2 asthma
    Papi, Alberto
    Corren, Jonathan
    Castro, Mario
    Domingo, Christian
    Rogers, Linda
    Chapman, Kenneth R.
    Jackson, Daniel J.
    Daizadeh, Nadia
    Pandit-Abid, Nami
    Gall, Rebecca
    Jacob-Nara, Juby A.
    Rowe, Paul J.
    Deniz, Yamo
    Ortiz, Benjamin
    ALLERGY, 2023, 78 (01) : 233 - 243
  • [9] Dupilumab efficacy in children with uncontrolled, moderate-to-severe type 2 asthma, with and without evidence of allergy, in the phase 3 VOYAGE study
    Papadopoulos, N. G.
    Szefler, S. J.
    Bacharier, L. B.
    Maspero, J. F.
    Domingo, C.
    Daizadeh, N.
    Lederer, D. J.
    Hardin, M.
    Jacob-Nara, J. A.
    Deniz, Y.
    Gall, R.
    Ortiz, B.
    Djandji, M.
    Rowe, P.
    ALLERGY, 2021, 76 : 175 - 176
  • [10] Dupilumab Efficacy and Safety in Children with Uncontrolled, Moderate-to-Severe Asthma: The Phase 3 VOYAGE Study
    Bacharier, L. B.
    Maspero, J. F.
    Katelaris, C. H.
    Fiocchi, A. G.
    Gagnon, R.
    de Mir, I
    Jain, N.
    Sher, L. D.
    Mao, X.
    Liu, D.
    Zhang, Y.
    Khan, A. H.
    Kapoor, U.
    Khokhar, F. A.
    Rowe, P.
    Deniz, Y.
    Ruddy, M.
    Laws, E.
    Amin, N.
    Mannent, L. P.
    Lederer, D. J.
    Hardin, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
12345